Bintang Mitra Semestaraya Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bintang Mitra Semestaraya Tbk trades at Rp306 (market cap 354.72B, 2.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Prodia Diagnostic Line Tbk is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 2.4K). Which is the better fit depends on your goals.
| BMSR | PRDL | |
|---|---|---|
Market Cap | 354.72B | 470.58B |
Volume | 2.4K | 28.43M |
Lot | 24 | 284.34K |
Turnover | 733.8K | 7.8B |
Average Price | 305.75 | 274.19 |
Value | 733.8K | 7.8B |
Indicative Equilibrium Price | — | 270 |
Indicative Equilibrium Volume | — | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bintang Mitra Semestaraya Tbk (the Company) was established on November 16, 1989 based on Notarial Deed No. 240 of Mrs Siti Pertiwi Henny Shidki, S.H., which had been amended by Notarial Deed No. 246 dated May 31, 1991 by the same Notary regarding the change of name from PT Bintang Mahkota Semestaraya into PT Bintang Mitra Semestaraya. BMSR is a company that concentrate its business on investing its capital on property companies. It generally invest its capital through subsidiary companies and groups in developing commercial buildings, apartments and general housing.
Read more on BMSR →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →